CLINICAL_TRIALS
trial_result
· 2012-11-12
Clinical Trial Update: Efficacy and Safety Study of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus [Phase 3]
Summary
A Phase 3 efficacy and safety study of TAK-559 in Type 2 diabetes mellitus has been terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED